MedTrace Logo

Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease

NCT00438932 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2011-09-27

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to learn more about how the kidneys control the blood levels of phosphorus in patients with early chronic kidney disease. The ultimate goal is to use this information to design improved treatment strategies for phosphorus-related problems for the millions of patients with chronic kidney disease.

Conditions

Interventions

DRUG

Lanthanum Carbonate

Lanthanum carbonate 1000mg 3x/day

DIETARY_SUPPLEMENT

Low Phosphorus Diet

Low phosphorus diet will consist of 800 mg of phosphorus per day.

DIETARY_SUPPLEMENT

Unrestricted Phosphorus Diet

Unrestricted diet will contain 1550 mg of phosphorus per day - 800 mg of which is dietary and 750mg of Neutraphos (3 packets/day); each packet is 250mg.

DRUG

Placebo

Lanthanum Carbonate placebo given three times a day with meals.

Sponsors & Collaborators

  • Shire

    collaborator INDUSTRY

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Myles Wolf, MD, MMSc · Univesity of Miami Miller School of Medicine

  • Harald Jueppner, MD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00438932 on ClinicalTrials.gov